Michael S. Kaminer

Dr. Michael S. Kaminer

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2008 in Dermatologic Surgery
Verified
Journal Article
Closed access
PDF file
MKMichael S. Kaminer
Michael S. Kaminer
MBMegan Bogart
Megan Bogart
CCChristine Choi
Christine Choi
SWSue Ann Wee
Sue Ann Wee

7 April 2021 in Dermatologic Surgery
Verified
Journal Article
Open access
JKJoely Kaufman-Janette
Joely Kaufman-Janette
JJJohn Joseph
John Joseph
MKMichael S. Kaminer
Michael S. Kaminer
JCJames Clark
James Clark
SFSabrina G. Fabi
Sabrina G. Fabi
LBLawrence S. Bass
Lawrence S. Bass
BACKGROUND: Fibrous septae play a role in contour alterations associated with cellulite. OBJECTIVE: To assess collagenase clostridium histolyticum-aaes (CCH) for the treatment of cellulite. MATERIALS AND METHODS: Two identically designed phase 3, double-blind, randomized studies (RELEASE-1 and RELEASE-2) were conducted. Adult women with moderate/severe cellulite (rating 3–4 on the Patient Reported Photonumeric Cellulite Severity Scale [PR-PCSS] and Clinician Reported PCSS [CR-PCSS]) on the buttocks received up to 3 treatment sessions of subcutaneous CCH 0.84 mg or placebo per treatment area. Composite response (≥2-level or ≥1-level improvement from baseline in both PR-PCSS and CR-PCSS) was determined at Day 71. RESULTS: Eight hundred forty-three women received ≥1 injection (CCH vs placebo: RELEASE-1, n = 210 vs n = 213; RELEASE-2, n = 214 vs n = 206). Greater percentages of CCH-treated women were ≥2-level composite responders versus placebo in RELEASE-1 (7.6% vs 1.9%; p = .006) and RELEASE-2 (5.6% vs 0.5%; p = .002) and ≥1-level composite responders in RELEASE-1 (37.1% vs 17.8%; p < .001) and RELEASE-2 (41.6% vs 11.2%; p < .001). Most adverse events (AEs) in the CCH group were injection site related; few CCH-treated women discontinued because of an AE (≤4.3%). CONCLUSION: Collagenase clostridium histolyticum-aaes significantly improved cellulite appearance and was generally well tolerated.

21 March 2006 in Dermatologic Surgery
Verified
Journal Article
Closed access
PDF file
DGDee Anna Glaser
Dee Anna Glaser
MKMichael S. Kaminer
Michael S. Kaminer

13 December 2023 in Dermatologic Surgery
Verified
Journal Article
Open access
ETElizabeth Tanzi
Elizabeth Tanzi
CCChristopher C. Capelli
Christopher C. Capelli
DRDavid Robertson
David Robertson
BLBrenda LaTowsky
Brenda LaTowsky
SBShenavia Balcom-Luker
Shenavia Balcom-Luker
MKMichael S. Kaminer
Michael S. Kaminer
BACKGROUND: Cellulite is an aesthetically displeasing rippling or dimpling of the skin, primarily on the buttocks/thighs. A recent study showed a novel acoustic subcision device produced significant short-term (12-week) improvement in the appearance of cellulite after a single rapid acoustic pulse (RAP) treatment. OBJECTIVE: To evaluate the long-term (>52-weeks) efficacy and safety of RAP treatment for improvement in the appearance of cellulite. MATERIALS AND METHODS: In this prospective, multicenter trial, female participants (n = 42) with severe cellulite were treated with the acoustic subcision device in a single visit. At >52 weeks, blinded board-certified dermatologists assessed efficacy by correctly identifying post-treatment photographs and using a 6-point simplified Cellulite Severity Scale (CSS). Participant satisfaction was also collected. Safety was assessed throughout. RESULTS: The blinded panel correctly identified post-treatment photographs at a rate of 95.2%; 70.4% of participants had a >1-point reduction in the CSS score from baseline (mean reduction of 1.09). All participants (100%) reported improved cellulite appearance. Overall pain during treatment was rated as 2.4 and 0.3 post-treatment (pain scale 0–10). No device or treatment-related adverse events were reported at the >52-week follow-up. CONCLUSION: Rapid acoustic pulse treatment significantly improved the long-term appearance of cellulite and was well-tolerated.

30 August 2023 in Dermatologic Surgery
Verified
Journal Article
Open access
AEAriel E. Eber
Ariel E. Eber
PHPerry B. Hooper
Perry B. Hooper
LMLeah BSN McCabe
Leah BSN McCabe
JDJeffrey S. Md Dover
Jeffrey S. Md Dover
MKMichael S. Kaminer
Michael S. Kaminer

1 November 2012 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
LFLarry K. Fan
Larry K. Fan
WCWilliam P. Coleman
William P. Coleman
DGDee Anna Glaser
Dee Anna Glaser
MKMichael S. Kaminer
Michael S. Kaminer
SKSuzanne L. Kilmer
Suzanne L. Kilmer
SSStacy R. Smith
Stacy R. Smith